Suppr超能文献

环氧化酶-2调节细胞生长并促进肿瘤发生。

Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis.

作者信息

Trifan O C, Hla T

机构信息

University of Connecticut Health Center, Center for Vascular Biology, Farmigton, CT 03032, USA.

出版信息

J Cell Mol Med. 2003 Jul-Sep;7(3):207-22. doi: 10.1111/j.1582-4934.2003.tb00222.x.

Abstract

Cyclooxygenase (COX)-2 and the prostaglandins resulting from its enzymatic activity have been shown to play a role in modulating cell growth and development of human neoplasia. Evidence includes a direct relationship between COX-2 expression and cancer incidence in humans and animal models, increased tumorigenesis after genetic manipulation of COX-2, and significant anti-tumor properties of non-steroidal anti-inflammatory drugs in animal models and in some human cancers. Recent data showed that COX-2 and the derived prostaglandins are involved in control of cellular growth, apoptosis, and signal through a group of nuclear receptors named peroxisome proliferator-activated receptors (PPARs). In this article we will review some of the findings suggesting that COX-2 is involved in multiple cellular mechanisms that lead to tumorigenesis.

摘要

环氧合酶(COX)-2及其酶活性产生的前列腺素已被证明在调节人类肿瘤的细胞生长和发展中发挥作用。证据包括COX-2表达与人类和动物模型中癌症发病率之间的直接关系、COX-2基因操作后肿瘤发生增加,以及非甾体抗炎药在动物模型和某些人类癌症中的显著抗肿瘤特性。最近的数据表明,COX-2和衍生的前列腺素通过一组名为过氧化物酶体增殖物激活受体(PPARs)的核受体参与细胞生长、凋亡和信号传导的控制。在本文中,我们将回顾一些表明COX-2参与导致肿瘤发生的多种细胞机制的研究结果。

相似文献

1
Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis.
J Cell Mol Med. 2003 Jul-Sep;7(3):207-22. doi: 10.1111/j.1582-4934.2003.tb00222.x.
2
Cancer research. Anti-inflammatories inhibit cancer growth--but how?
Science. 2001 Jan 26;291(5504):581-2. doi: 10.1126/science.291.5504.581.
8
Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands as bifunctional regulators of cell proliferation.
Biochem Pharmacol. 2003 Oct 15;66(8):1381-91. doi: 10.1016/s0006-2952(03)00488-x.
10
Cyclooxygenase-2 inhibitors in tumorigenesis (Part II).
J Natl Cancer Inst. 1998 Nov 4;90(21):1609-20. doi: 10.1093/jnci/90.21.1609.

引用本文的文献

2
PDIA3 Expression in Glioblastoma Modulates Macrophage/Microglia Pro-Tumor Activation.
Int J Mol Sci. 2020 Nov 3;21(21):8214. doi: 10.3390/ijms21218214.
3
Pyruvate Kinase M2 Promotes Prostate Cancer Metastasis Through Regulating ERK1/2-COX-2 Signaling.
Front Oncol. 2020 Sep 29;10:544288. doi: 10.3389/fonc.2020.544288. eCollection 2020.
4
Single Nucleotide Variants Associated with Colorectal Cancer Among Iranian Patients: A Narrative Review.
Pharmgenomics Pers Med. 2020 Jun 3;13:167-180. doi: 10.2147/PGPM.S248349. eCollection 2020.
5
Suppression of the solar ultraviolet-induced skin carcinogenesis by TOPK inhibitor HI-TOPK-032.
Oncogene. 2020 May;39(21):4170-4182. doi: 10.1038/s41388-020-1286-4. Epub 2020 Apr 10.
6
Anti-metastatic Properties of Naproxen-HBTA in a Murine Model of Cutaneous Melanoma.
Front Pharmacol. 2019 Feb 8;10:66. doi: 10.3389/fphar.2019.00066. eCollection 2019.
8
Targeting PRPK and TOPK for skin cancer prevention and therapy.
Oncogene. 2018 Oct;37(42):5633-5647. doi: 10.1038/s41388-018-0350-9. Epub 2018 Jun 14.
9
Expression and clinical significance of cyclooxygenase 2 and survivin in human gliomas.
Oncol Lett. 2017 Aug;14(2):1303-1308. doi: 10.3892/ol.2017.6281. Epub 2017 May 31.
10
Dual effects of acetylsalicylic acid on ERK signaling and Mitf transcription lead to inhibition of melanogenesis.
Mol Cell Biochem. 2016 Jan;412(1-2):101-10. doi: 10.1007/s11010-015-2613-x. Epub 2015 Dec 23.

本文引用的文献

5
APC-dependent suppression of colon carcinogenesis by PPARgamma.
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13771-6. doi: 10.1073/pnas.162480299. Epub 2002 Oct 7.
7
A novel pathway of prostacyclin signaling-hanging out with nuclear receptors.
Endocrinology. 2002 Sep;143(9):3207-10. doi: 10.1210/en.2002-220159.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验